P38 MAPK and NF-κB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells

Cancer Letters

Volumn 295, Issue 1, 2010, Pages 92-99

  Chiu, Chien Chih ^a   Chen, Jeff Yi Fu ^a   Lin, Kuwi Li ^a   Huang, Chi Jung ^a   Lee, Jin Ching ^a   Chen, Bin Hung ^a   Chen, Wan Yu ^a   Lo, Yi Han ^a   Chen, Yi Lan ^a   Tseng, Chih Hua ^a   Chen, Yeh Long ^a   Lin, Shinne Ren ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepatocellular carcinoma (HCC); Naphthoquinone; NF B; P38 MAPK

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NAPHTHO[1,2 B]FURAN 4,5 DIONE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRAIN HEPG2; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; BCL-X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; NAPHTHOQUINONES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77953611988     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.02.017     Document Type: Article

References (33)

1. Wang S.W., Pan S.L., Huang Y.C., Guh J.H., Chiang P.C., Huang D.Y., Kuo S.C., Lee K.H., Teng C.M. CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo. Mol. Cancer Ther. 2008, 7:350-360.
2. Lee Y.R., Kim B.S., Jung Y.U., Koh W.S., Cha J.S., Kim N.W. Facile synthesis of avicequinone-B natural product. Synth. Commun. 2002, 32:3099-3105.
3. Chen Y.L., Chen I.L., Wang T.C., Han C.H., Tzeng C.C. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives. Eur. J. Med. Chem. 2005, 40:928-934.
4. Tseng C.H., Lin C.S., Shih P.K., Tsao L.T., Wang J.P., Cheng C.M., Tzeng C.C., Chen Y.L. Furo[3',2':3,4] naphtho[1,2-d] imidazole derivatives as potential inhibitors of inflammatory factors in sepsis. Bioorg. Med. Chem. 2009, 17:6773-6779.
5. Kongkathip N., Kongkathip B., Siripong P., Sangma C., Luangkamin S., Niyomdecha M., Pattanapa S., Piyaviriyagul S., Kongsaeree P. Potent antitumor activity of synthetic 1,2-naphthoquinones and 1,4-naphthoquinones. Bioorg. Med. Chem. 2003, 11:3179-3191.
6. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
7. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
8. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 2000, 275:39435-39443.
9. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell 2002, 109(Suppl.):S81-S96.
10. Shishodia S., Aggarwal B.B. NF-κB: a friend or a foe in cancer?. Biochem. Pharmacol. 2004, 68:1071-1080.
11. Wu J., Maluccio M. NF-κB inhibition in human hepatocellular carcinoma: a potential adjunct to sorafenib based therapy. J. Surg. Res. 2009, 151:259.
12. Lee H.J., Wang C.J., Kuo H.C., Chou F.P., Jean L.F., Tseng T.H. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol. Appl. Pharmacol. 2005, 203:124-131.
13. Fan J., Li R., Zhang R., Liu H.L., Zhang N., Zhang F.Q., Dou K.F. Effect of Bcl-2 and Bax on survival of side population cells from hepatocellular carcinoma cells. World J. Gastroenterol. 2007, 13:6053-6059.
14. Salakou S., Kardamakis D., Tsamandas A.C., Zolota V., Apostolakis E., Tzelepi V., Papathanasopoulos P., Bonikos D.S., Papapetropoulos T., Petsas T., Dougenis D. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 2007, 21:123-132.
15. Lee S.H., Park S.M., Park J.H., Shin D.Y., Kim G.Y., Ryu C.H., Shin S.C., Jung J.M., Kang H.S., Lee W.S., Choi Y.H. Induction of apoptosis in human leukemia U937 cells by anthocyanins through down-regulation of Bcl-2 and activation of caspases. Int. J. Oncol. 2009, 34:1077-1083.
16. Chanvorachote P., Pongrakhananon V., Wannachaiyasit S., Luanpitpong S., Rojanasakul Y., Nimmannit U. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Cancer Invest. 2009, 27:624-635.
17. Fang J., Gu L., Zhu N., Tang H., Alvarado C.S., Zhou M. Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells. BMC Cancer 2008, 8:69.
18. Droga-Mazovec G., Bojic L., Petelin A., Ivanova S., Romih R., Repnik U., Salvesen G.S., Stoka V., Turk V., Turk B. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 2008, 283:19140-19150.
19. Rieber M., Rieber M.S. Mcl-1 cleavage and sustained phosphorylation of c-Jun-N-terminal kinase mediate melanoma apoptosis induced by 2-acetyl furanonaphthoquinone: roles of Bcl-2 and p53. Cancer Biol. Ther. 2008, 7:1206-1211.
20. Chen L.N., Wang Y., Ma D.L., Chen Y.Y. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 2006, 11:101-111.
21. Hsu S.C., Yang J.S., Kuo C.L., Lo C., Lin J.P., Hsia T.C., Lin J.J., Lai K.C., Kuo H.M., Huang L.J., Kuo S.C., Wood W.G., Chung J.G. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J. Orthop. Res. 2009, (Epub ahead of print).
22. Coulthard L.R., White D.E., Jones D.L., McDermott M.F., Burchill S.A. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 2009, 15:369-379.
23. Michaelidis B., Hatzikamari M., Antoniou V., Anestis A., Lazou A. Stress activated protein kinases, JNKs and p38 MAPK, are differentially activated in ganglia and heart of land snail Helix lucorum (L.) during seasonal hibernation and arousal. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2009, (Epub ahead of print).
24. Watson J.L., Greenshields A., Hill R., Hilchie A., Lee P.W., Giacomantonio C.A., Hoskin D.W. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol. Carcinog. 2009, (Epub ahead of print).
25. Rosini P., De Chiara G., Lucibello M., Garaci E., Cozzolino F., Torcia M. NGF withdrawal induces apoptosis in CESS B cell line through p38 MAPK activation and Bcl-2 phosphorylation. Biochem. Biophys. Res. Commun. 2000, 278:753-759.
26. Geest C.R., Buitenhuis M., Groot Koerkamp M.J., Holstege F.C., Vellenga E., Coffer P.J. Tight control of MEK-ERK activation is essential in regulating proliferation, survival and cytokine production of CD34+ derived neutrophil progenitors. Blood 2009, (Epub ahead of print).
27. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., Keyomarsi K., Yarden Y., Seger R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001, 20:147-155.
28. Tergaonkar V. NF-κB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol. 2006, 38:1647-1653.
29. Shen H.M., Tergaonkar V. NF-κB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
30. Freudlsperger C., Greten J., Schumacher U. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NF-κB. Anticancer Res. 2008, 28:209-214.
31. Lu T., Stark G.R. Cytokine overexpression and constitutive NF-κB in cancer. Cell Cycle 2004, 3:1114-1117.
32. Konturek P.C., Nikiforuk A., Kania J., Raithel M., Hahn E.G., Muhldorfer S. Activation of NF-κB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig. Dis. Sci. 2004, 49:1075-1083.
33. Gross A., McDonnell J.M., Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 1999, 13:1899-1911.